semaglutide clinical trials near me Wegovy shown to reduce risk of heart attack, stroke in major cardiovascular trial AD/PD 2026: Novo Nordisk's semaglutide

The PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes trial is a multicenter study evaluating GLP-1 RAs versus SGLT2i for both primary and secondary prevention of ASCVD in patients with T2DM [62]

Johnson, MD, Chief Medical Director of CenExel Metabolic and Principal Investigator, and Margot Witteveen, MS, RDN, LD, Research Registered Dietitian Nutritionist at CenExel Decatur, highlight why monitoring nutritional adequacy is critical in metabolic studies

Why Some Patients Report Dizziness on Semaglutide Rapid improvements in blood glucose control can trigger temporary dizziness, especially in patients with longstanding elevated blood sugar levels or those already taking diabetes medications

The frustration is real, but the stall is usually fixable

Hers offers a few more budget-friendly treatments, though they include non-GLP-1, non-FDA-approved compounded products

Recent health insurance data from France are indicative of an elevated risk of medullary thyroid carcinoma in individuals treated with GLP-1RAs versus other glucose-lowering agents (35 cases, hazard ratio [HR] 1.78 [95% CI 1.043.05]) (78)